Mesirow Financial Investment Management International Equity »

Praxis Precision Medicines I shares owned by Mesirow Financial Investment Management International Equity

Quarter-by-quarter ownership of Praxis Precision Medicines I (PRAX) shares owned by Mesirow Financial Investment Management International Equity from 13F filings

Historical chart of Mesirow Financial Investment Management International Equity investment in Praxis Precision Medicines I

Tip: Access up to 7 years of quarterly data

All positions including Praxis Precision Medicines I held by Mesirow Financial Investment Management International Equity consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Praxis Precision Medicines I by Mesirow Financial Investment Management International Equity

Quarter filed Position value Share count Share price at filing
2024-09-30 $231k 4.0k 57.54

More positions owned by Mesirow Financial Investment Management International Equity

Berkshire Hathaway Inc Del Cl B New (BRK.B)
Apple (AAPL)
Vaneck Etf Trust Mrngstr Wde Moat (MOAT)
Ishares Tr Core S&p Scp Etf (IJR)
Vanguard Whitehall Fds High Div Yld (VYM)
Ishares Tr Core S&p500 Etf (IVV)
Microsoft Corporation (MSFT)
Ishares Tr Core S&p Ttl Stk (ITOT)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Alphabet Cap Stk Cl C (GOOG)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon (AMZN)
Ishares Tr Rus 1000 Grw Etf (IWF)
Alphabet Cap Stk Cl A (GOOGL)

View all positions for Mesirow Financial Investment Management International Equity

Top funds holding Praxis Precision Medicines I

BlackRock
BlackRock
Point72 Asset Management
Perceptive Advisors
T. Rowe Price Associates
Capital Research Global Investors
Vanguard Group
State Street Corporation
RA Capital Management
Verition Fund Management
VR Adviser
Cormorant Asset Management
Soleus Capital Management
Franklin Resources
Kingdon Capital Management

View all funds holding Praxis Precision Medicines I